# Botulinum Type A Toxin in the Treatment of Lateral Canthal Lines (Crow's Feet)

> **NCT00247559** · PHASE2 · COMPLETED · sponsor: **Ipsen** · enrollment: 221 (actual)

## Conditions studied

- Lateral Canthal Lines

## Interventions

- **BIOLOGICAL:** Botulinum toxin type A

## Key facts

- **NCT ID:** NCT00247559
- **Lead sponsor:** Ipsen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-05
- **Primary completion:** 2005-04-08
- **Final completion:** 2005-04-08
- **Target enrollment:** 221 (ACTUAL)
- **Last updated:** 2019-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00247559

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00247559, "Botulinum Type A Toxin in the Treatment of Lateral Canthal Lines (Crow's Feet)". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT00247559. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*